Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision entry labeled 'Revision: v3.6.5' was added to the study record history, representing an update to the page content. The previous revision 'Revision: v3.6.4' was removed from the history.
    Difference
    0.1%
    Check dated 2026-08-11T18:22:21.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the study record history, replacing the previous revision v3.6.3, indicating an administrative update to the record.
    Difference
    0.1%
    Check dated 2026-07-21T13:23:05.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision history now shows a new entry for revision v3.6.3, and the previous revision v3.6.2 is removed, updating the documented version history to reflect the latest release.
    Difference
    0.1%
    Check dated 2026-07-07T02:43:05.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The history now adds a new Revision: v3.6.2 entry and removes the previous Revision: v3.6.0 entry, indicating an update to the page's underlying revision in the record history.
    Difference
    0.1%
    Check dated 2026-06-29T17:50:58.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added 'No longer looking for participants' to the study history, indicating recruitment is paused. The history also shows a new 'Revision: v3.6.0' entry and the removal of the previous 'Revision: v3.5.5' entry.
    Difference
    0.4%
    Check dated 2026-06-15T08:47:21.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    A newer revision entry (v3.5.5) was added to the study's version history, replacing the previous revision (v3.5.4) and signaling an update to the record metadata.
    Difference
    0.1%
    Check dated 2026-06-08T05:32:14.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.